ECMO:体外膜肺氧合(第2版)
上QQ阅读APP看书,第一时间看更新

参考文献

1.中华医学会心血管病学分会,中华心血管病杂志编辑委员会.中国心力衰竭诊断和治疗指南2014.中华心血管病杂志,2014,42(2):98-122.
2.张宇辉,张健,卿恩明,等.国产左西孟旦与多巴酚丁胺治疗急性失代偿性心力衰竭患者临床研究.中华心血管病杂志,2012,40:153-156.
3.Reynolds HR,Hochman JS.Cardiogenic shock:currentconcepts and improving outcomes.Circulation,2008,117(5):686-697.
4.Januzzi JL,van Kimmenade R,Lainchburv J,et al.NT-pro BNP testing for diagnosis and short-term prognosis in acute destabilized heart failure:an internalional pooled analysis of 1256 patients:the Intemational Collaborative of NT-pro BNP study.Eur Heart J,2006,27(3):330-337.
5.Konstam MA,Gheorghiade M,Burnett JC Jr,el a1.Effects of oral tolvaptan in patients hospitalized for worsening heart failure:the EVEREST Outcome Trial.JAMA,2007,297(12):1319-1331.
6.Yancy CW,Singh A.Potential applications of outpatient nesiritide infusions in patients with advanced heart failure and concomitant renal insuffciency(from the Follow-up Serial Infusions of Nesirilide [FUSION Ⅰ] trial).Am J Cardiol,2006,98(2):226-229.
7.Yancy CW,Krum H,Massie BM,et al.The Second Followup Serial Infusions of Nesiritide(FUSIONⅡ)trial for advanced heart failure:study rationale and design.Am Heart J,2007,153(4):478-484.
8.Cuffe MS,Califf RM,Adams KF Jr,et al.Shorttermintravenous milrinone for acute exacerbation of chronic heart failure:a randomized controlled trail.JAMA,2002,287(12):1541-1547.
9.Mebazaa A,Nieminen MS,Packer M,et al.Levosimendan vs dobutamine for patients with acute decompensated heart failure:the SURVIVE Randomized Trial.JAMA,2007,297(17):1883-1891.
10.McKelvie RS,Moe GW,Ezekowitz JA,et al.The 2012 Canadian Cadiovascular Society heart failure management guidelines update:focus on acute and chronic heart failure.Can J Cardiol,2013,29(2):168-181.